Karpus Management Amends Nuveen NY Muni Fund Stake

TL;DR

**Karpus Management updated their stake in Nuveen NY Muni Fund, signaling a potential shift in their investment thesis.**

AI Summary

Karpus Management, Inc. filed an amended Schedule 13D/A on January 8, 2024, regarding its ownership in Nuveen New York AMT-Free Quality Municipal Income Fund. This amendment, dated January 5, 2024, indicates a change in their beneficial ownership, requiring an update to their previous filings. This matters to investors because Karpus Management, Inc. is a significant shareholder, and changes in their holdings or intentions can signal shifts in their view of the fund's value or future direction, potentially influencing other investors.

Why It Matters

This filing updates the public on Karpus Management, Inc.'s beneficial ownership in the Nuveen New York AMT-Free Quality Municipal Income Fund, which can influence market perception and the fund's stock price.

Risk Assessment

Risk Level: low — This is an amendment to a previous filing, indicating an update to ownership rather than a new, potentially disruptive event.

Analyst Insight

Investors should review the full SC 13D/A filing to understand the specific changes in Karpus Management, Inc.'s beneficial ownership and any stated intentions, as this could influence the fund's future performance or strategic direction.

Key Players & Entities

• Karpus Management, Inc. (company) — the entity filing the SC 13D/A, reporting beneficial ownership
• Nuveen New York AMT-Free Quality Municipal Income Fund (company) — the subject company in which Karpus Management, Inc. holds shares
• Daniel L. Lippincott (person) — President and Chief Investment Officer of Karpus Management, Inc.
• Adam W. Finerman, Esq. (person) — Attorney at BakerHostetler authorized to receive notices for Karpus Management, Inc.
• January 5, 2024 (date) — Date of the event requiring the filing of this statement

FAQ

Key Financial Figures

• $212,224,575 — cially owned by Karpus is approximately $212,224,575.40, excluding brokerage commissions. Th
• $10.55 — TS) Purchase of Common Stock 26,976 $10.55 12/22/2023 Purchase of Common Stock
• $10.56 — 23 Purchase of Common Stock 153,071 $10.56 12/26/2023 Sale of Common Stock (3,
• $11.14 — 6/2023 Sale of Common Stock (3,684) $11.14 12/27/2023 Purchase of Common Stock
• $10.59 — 023 Purchase of Common Stock 91,886 $10.59 12/28/2023 Purchase of Common Stock
• $10.54 — 23 Purchase of Common Stock 156,933 $10.54 12/29/2023 Purchase of Common Stock
• $10.51 — 023 Purchase of Common Stock 43,017 $10.51 1/2/2024 Purchase of Common Stock 5
• $10.53 — 024 Purchase of Common Stock 35,458 $10.53 1/4/2024 Purchase of Common Stock 1

Filing Documents

• karpus-sch13d_18788.htm (SC 13D/A) — 94KB
• exh-1_18788.htm (EX-1) — 1KB
• nrk_letter-1.jpg (GRAPHIC) — 485KB
• nrk_letter-2.jpg (GRAPHIC) — 629KB
• nrk_letter-3.jpg (GRAPHIC) — 302KB
• 0001072613-24-000026.txt ( ) — 2048KB

Interest

Item 5. Interest in Securities of the Issuer . Item 5(a)-(c) are hereby amended to read as follows: (a) As of the close of business on January 5, 2024 Karpus beneficially owned an aggregate of 19,678,836.15 Shares held in the Accounts, which represents approximately 22.56% of the 87,235,304 Shares reported as outstanding as of August 31, 2023 on the Form N-CSR filed by the Issuer for the semi-annual period ended August 31, 2023. (b) 1. Sole power to vote or direct vote:19,333,836.15 2. Shared power to vote or direct vote: 0 3. Sole power to dispose or direct the disposition:19,678,836.15 4. Shared power to dispose or direct the disposition:0 (c) The transactions in the Shares by Karpus through the Accounts since the amended Schedule 13D filing on December 26, 2023 are set forth on Schedule B and incorporated herein for reference.

Material

Item 7. Material to be Filed as Exhibits . Item 7 of the Original Schedule 13D is hereby amended to add the following exhibit: Exhibit No. Description 1 Letter to the Board, dated January 5, 2024. CUSIP No.670656107 13D Page 5 of 6 Pages SIGNATURE After reasonable inquiry and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: January 8, 2024 KARPUS MANAGEMENT, INC. By: /s/ Daniel L. Lippincott Name: Daniel L. Lippincott Title: President and Chief Investment Officer CUSIP No. 670656107 13D Page 6 of 6 Pages SCHEDULE A Executive Officers & Directors of Karpus Management, Inc., d/b/a Karpus Investment Management Name Position & Present Principal Occupation

Business

Owned Kathleen Finnerty Crane Chief Financial Officer 183 Sully’s Trail, Pittsford, New York 14534 150 Shares Thomas Michael Duffy Senior Vice President and Director of Operations 183 Sully’s Trail, Pittsford, New York 14534 0 Shares Daniel Lee Lippincott President and Chief Investment Officer 183 Sully’s Trail, Pittsford, New York 14534 4,300 Shares Brett David Gardner Senior Vice President 183 Sully’s Trail, Pittsford, New York 14534 1,275 Shares Jodi Lee Hedberg Chief Compliance Officer 183 Sully’s Trail, Pittsford, New York 14534 0 Shares Thomas Wayne Griffin Director 17 East Market Street, West Chester, Pennsylvania 19382 90 0 Shares Carlos Manuel Yuste Director 17 East Market Street, West Chester, Pennsylvania 19382 0 Shares SCHEDULE B Transactions in the Shares since the amended Schedule 13D filing on December 26, 2023 Nature of the Transaction Shares Purchased/(Sold) Price Per Share($) Date of Purchase / Sale KARPUS MANAGEMENT, INC., D/B/A/ KARPUS INVESTMENT MANAGEMENT (THROUGH THE ACCOUNTS) Purchase of Common Stock 26,976 $10.55 12/22/2023 Purchase of Common Stock 153,071 $10.56 12/26/2023 Sale of Common Stock (3,684) $11.14 12/27/2023 Purchase of Common Stock 91,886 $10.59 12/28/2023 Purchase of Common Stock 156,933 $10.54 12/29/2023 Purchase of Common Stock 43,017 $10.51 1/2/2024 Purchase of Common Stock 54,009 $10.56 1/3/2024 Purchase of Common Stock 35,458 $10.53 1/4/2024 Purchase of Common Stock 17,059 $10.53 1/5/2024

View Full Filing

View this SC 13D/A filing on SEC EDGAR